Clinical Study
Residual Renal Function in Hemodialysis Patients: The Role of Angiotensin-Converting Enzyme Inhibitor in Its Preservation
Table 1
Clinical characteristics at recruitment of treatment and control groups.
| | | Enalapril group | Control group | |
| | Number of patients () |
21
|
21
| n.s. | | Sex (M/F) | | | n.s. | | Age (years) | | | n.s. | | BMI (Kg/m2) | | | n.s. | | GFR at initiation of HD (mL/min/1.73 m2) | | | n.s. | | Loop diuretics |
17
|
16
| n.s. | | C-reactive protein (mg/dL) | | | n.s. |
| | Primary kidney disease |
| | Diabetes | 6 | 5 | | | Glomerulonephritis | 5 | 5 | | | Hypertension | 3 | 2 | | | PKD | 2 | 1 | | | Unknown/various | 5 | 8 | |
|
|
Values are expresses as mean ± SD.
|
